BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 2566541)

  • 21. Acid secretion and acid suppression in pathogenesis and healing of peptic ulcer disease.
    Thomson AB
    Hepatogastroenterology; 1990 Jul; 37 Suppl 1():18-28. PubMed ID: 1976583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Famotidine therapy for active duodenal ulcers. A multivariate analysis of factors affecting early healing.
    Reynolds JC
    Ann Intern Med; 1989 Jul; 111(1):7-14. PubMed ID: 2567589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Famotidine in the short-term treatment of duodenal ulcer and of concomitant peptic lesions: comparison with cimetidine.
    Polloni A; Marchi S; Greco A; Cipparrone G; Costa F; Bellini M; Maltinti G
    Int J Clin Pharmacol Res; 1988; 8(2):139-42. PubMed ID: 3378855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multicenter, randomized, double-blind study comparing famotidine with cimetidine in the treatment of active duodenal ulcer disease.
    Rodrigo L; Viver J; Conchillo F; Barrio E; Forné M; Zozaya JM; Alvarez A; Dieguez P; Muñoz M; Panés J
    Digestion; 1989; 42(2):86-92. PubMed ID: 2570005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A single nocte dose of famotidine in the treatment of duodenal ulcer.
    Qureshi H; Ahmad W; Zuberi SJ
    J Pak Med Assoc; 1989 Apr; 39(4):104-6. PubMed ID: 2568508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical review of histamine2 receptor antagonists.
    Lipsy RJ; Fennerty B; Fagan TC
    Arch Intern Med; 1990 Apr; 150(4):745-51. PubMed ID: 1970232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of cigarette smoking on healing and relapse in duodenal ulcer disease.
    Korman MG; Hansky J; Eaves ER; Schmidt GT
    Gastroenterology; 1983 Oct; 85(4):871-4. PubMed ID: 6136450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [H2-blocker refractory ulcers: what can be done?].
    Dammann HG
    Z Gastroenterol; 1992 Apr; 30(4):268-71. PubMed ID: 1351328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Healing-promoting action of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl]urea with dual action on chronic gastric and duodenal ulcers induced by acetic acid in rats.
    Sekiguchi H; Hamada K; Aijima H; Taga F; Uchida H; Nishino K
    Arzneimittelforschung; 1993 Feb; 43(2):139-43. PubMed ID: 8096134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy of duodenal ulcer with H2-blockers. 2 x 150 mg ranitidine versus 2 x 400 mg cimetidine].
    Hüttemann W
    Fortschr Med; 1983 Jan; 101(4):139-41. PubMed ID: 6131857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Famotidine in the short and long-term treatment of duodenal ulcer.
    Zaterka S; de Paula Castro L; Villalobos JJ; Massuda HK; Eisig JN; Dias Avelar C; Coelho LG; Bettarello A
    Acta Gastroenterol Latinoam; 1988; 18(2):115-21. PubMed ID: 3075106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of changing the type of H2-blocker in the treatment of H2-blocker-resistant ulcers: comparison of roxatidine acetate hydrochloride and other H2-blockers.
    Yasutake K; Amano M; Mizokami Y; Kubota S; Fukumoto H; Imamura Y; Yokoya H; Irie K
    J Int Med Res; 1998; 26(1):25-36. PubMed ID: 9513074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of famotidine and ranitidine in duodenal ulcer].
    Rohner HG; Gugler R; Kimmig JM; Schönekäs H
    Dtsch Med Wochenschr; 1987 Feb; 112(9):367-8. PubMed ID: 2880704
    [No Abstract]   [Full Text] [Related]  

  • 34. Roxatidine versus ranitidine in the treatment of duodenal ulcer: a randomized, double blind, controlled, multicenter study in Thailand.
    Kachintorn U; Chinapak O; Vongphanich V; Kositchaiwat C; Lekhayananda S; Khow-ean U; Suttinont C; Saowaros V; Kludchareon N; Leethochawalit M
    J Med Assoc Thai; 1995 Dec; 78(12):641-7. PubMed ID: 8868007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of active duodenal ulcers with famotidine. A double-blind comparison with ranitidine.
    Rohner HG; Gugler R
    Am J Med; 1986 Oct; 81(4B):13-6. PubMed ID: 2877569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Famotidine in the management of duodenal ulcer: an analysis of multicenter findings worldwide.
    Reynolds JC
    Clin Ther; 1988; 10(4):436-49. PubMed ID: 3079011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of acute duodenal ulcers with famotidine and its comparison with other H2 blockers.
    Akhtar MA; Rashid P; Khan MA
    J Pak Med Assoc; 1990 Jun; 40(6):136-7. PubMed ID: 1975277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of gastric ulcer with famotidine. (Multicenter study)].
    Bernal Sahagún F; Barinagarrementería AR; Barrera Ríos L; Briseño Velazco S; Casillas Romo A; Corral Medina A; De la Torre Bravo A; Díaz de León E; Díaz Seoane R; Gallo Reynoso S
    Rev Gastroenterol Mex; 1989; 54(1):7-11. PubMed ID: 2667079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low dose, short duration therapy for the eradication of Helicobacter pylori in patients with duodenal ulcer.
    Iser JH; Buttigieg RJ; Iseli A
    Med J Aust; 1994 Feb; 160(4):192-6. PubMed ID: 7906009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of nizatidine and cimetidine as once-nightly treatment of acute duodenal ulcer. Nizatidine Multicenter Duodenal Ulcer Study Group.
    Cherner JA; Cloud ML; Offen WW; Latz JE
    Am J Gastroenterol; 1989 Jul; 84(7):769-74. PubMed ID: 2568086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.